Subscription Required

Only paid subscribers* to Specialty Pharmacy News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Specialty Pharmacy News receive

  • 12 monthly issues packed with news and strategies on this increasingly vital sector in health business, delivered First Class by U.S. Mail and electronically (optional),
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from Managing Editor Angela Maas.
View a sample and get more information
August 2014

Recent Stories of Interest

From Specialty Pharmacy News - Almost four-and-a-half years after the Biologics Price Competition and Innovation Act of 2009 was passed as part of the Affordable Care Act, the FDA finally has accepted an application for a drug seeking approval through the 351(k) biosimilar pathway established in the BPCIA. Sandoz said July 24 that the FDA had accepted its application for biosimilar filgrastim, making it the first company to disclose such information. Industry expectations are that approval could come next year, ushering in a new era of potential cost savings through greater competition in the U.S. Read more

A closely watched pilot program in oncology conducted by UnitedHealthcare has not… Read more

The country’s largest independent specialty pharmacy is going public. Diplomat Pharmacy, Inc.,… Read more

Consumer advocacy groups in California and Florida have taken various actions against… Read more

From the Editor

Welcome to your Specialty Pharmacy News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with your comments on the last issue of Specialty Pharmacy News, story ideas for future issues, or any other suggestions you have that can make the newsletter more useful for you.

August 21, 2014
Were WAG Execs Ousted for Major Forecasting Error

Were two Walgreens execs ousted for major forecasting error?

August 19, 2014
FDA Approves Oral Drug for Gaucher Disease

FDA approves Genzyme’s Cerdelga (eliglustat) for certain adults with Gaucher disease type 1; drug is only first-line oral therapy for indication

August 18, 2014
FDA Approves Next-Generation Avonex for MS

FDA approves Biogen Idec’s Plegridy, a pegylated interferon to treat MS that’s dosed every two weeks; drug is next-generation version of Avonex, which has weekly dosing

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to!

Why do I need to register?